Myocardial contrast echocardiography

Current Problems in Cardiology

Volumn 22, Issue 11, 1997, Pages 549-640

  Kaul, Sanjiv ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HUMAN; METHODOLOGY; REVIEW; UTILIZATION REVIEW;

ANIMALS; CORONARY CIRCULATION; CORONARY DISEASE; ECHOCARDIOGRAPHY; HUMANS;

EID: 0031264509     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0146-2806(97)80011-4     Document Type: Article

References (29)

1. DeMaria AN, Bommer WJ, Rigg SK, Dejee A, Keown M, Ling Kwan O, et al. Echocardiographic visualization of myocardial perfusion by left heart and intracoronary injection of echo contrast agents [abstract]. Circulation 1980;60(Suppl III):III-143.
2. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989;65:458-67.
3. Skyba DM, Jayaweera AR, Goodman NC, Ismail S, Camarano GP, Kaul S. Quantification of myocardial perfusion with myocardial contrast echocardiography from left atrial injection of contrast: implications for venous injection. Circulation 1994;90:1513-21.
4. Villanueva FS, GlasheenWP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation 1993;88:596-604.
5. Kassab GS, Lin DH, Fung YB. Morphometry of pig coronary venous system. Am J Physiol 1994;267:H2100-13.
6. Kassab GS, Lin DH, Fung YB. Morphometry of pig coronary arterial trees. Am J Physiol 1993;265:H350-65.
7. Kassab GS, Lin DH, Fung YB. Topology and dimensions of pig coronary capillary network. Am J Physiol 1994;267:H319-25.
8. Marcus ML. Anatomy of the coronary vasculature. In: Marcus ML, editor. The coronary circulation in health and disease. New York: McGraw-Hill; 1983. p. 3-21.
9. Tschabitscher M. Anatomy of coronary veins. In: MohlW, Wolner E, Glogar D, editors. The coronary sinus: proceedings of the first international symposium on myocardial protection via the coronary sinus. Darmstadt: Steinkopff-Verlag; 1984. p. 8-25.
10. Bassingthwaighte JB, Yipintsoi T, Harvey RB. Microvasculature of the dog left ventricular myocardium. Microvasc Res 1974;7:229-49.
11. Anderson WD, Anderson WB, Seguin RJ. Microvasculature of the bear heart demonstrated by scanning electron microscopy. Acta Anat 1988;131:305-13.
12. Batra S, Konig MF, Cruz-Orive. Unbiased estimation of capillary length from vertical slices. J Microsc 1995;178:152-9.
13. Wright K, Karlsson B. Fractal analysis and stereological evaluation of microstructures. J Microsc 1983;129:85-200.
14. 2 in individual cardiac myocytes in dogs, cats, rabbits, ferrets, and rats. Am J Physiol 1991;260:H552-31.
15. de Jong N. Basic principles of ultrasound contrast agents. In: de Jong N, editor. Acoustic properties of ultrasound contrast agents. Woerden: Zuidam and Zonen bv; 1993. p. 17-36.
16. Armstrong WF, West SR, Mueller TM, Dillon JC, Feigenbaum H. Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation 1982;66:166-73.
17. Tei C, Sakamaki T, Shah PM, Meerbaum S, Shimoura K, Kondo S, et al. Myocardial contrast echocardiography: a reproducible technique for myocardial opacification for identifying regional perfusion deficits. Circulation 1983;67:585-93.
18. Kemper AJ, O'Boyle JE, Sharma S, et al. Hydrogen peroxide contrast enhanced two-dimensional echocardiography: real-time in-vivo delineation of regional myocardial perfusion. Circulation 1983;68:603-11.
19. Feinstein SB, Ten Cate F, Zwehl W, et al. Two-dimensional contrast echocardiography, I: in vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 1984;3:14-20.
20. Gillam LD, Kaul S, Fallon JT, et al. Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidney. J Am Coll Cardiol 1985;6:687-94.
21. Moore CA, Smucker ML, Kaul S. Myocardial contrast echocardiography in humans, I: safety - a comparison with routine coronary arteriography. J Am Coll Cardiol 1986;8:1066-72.
22. Keller MW, Glasheen W, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of myocardial perfusion. J Am Coll Cardiol 1988;12:1039-47.
23. Lang RM, Borow KM, Neumann A, Al-Sadir J, Feinstein SB. Effects of intracoronary injection of sonicated microbubbles on left ventricular contractility. Am J Cardiol 1987;60:166-71.
24. Keller MW, Glasheen WP, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr 1989;2:48-52.
25. Ten Cate FJ, Widimsky P, Cornel JH, Waldstein DJ, Serruys PW, Waaler A. Intracoronary Albunex: its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. Circulation 1993;88:2123-7.
26. Hellebust H, Christiansen C, Skotland T. Biochemical characterization of air-filled albumin microspheres. Biotechnol Appl Biochem 1993;18:227-9.
27. Walday P, Tolleshaug H, Gjoen T, et al. Biodistributions of air-filled albumin microspheres in rats and pigs. Biochem J 1994;299:437-43.
28. Christiansen C, Vebner AJ, Muan B, et al. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres. Int Arch Allergy Immunol 1994;104:372-8.
29. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990;16:316-24.